Latest Close
$0.40
News
NXL
Nexalin Technology, Inc. News
This news view pulls recent coverage and headlines tied to NXL.
1y Change
-$1.45 (-78.27%)
Market Cap
$8,269,705.00
Sector
Healthcare
Industry
Medical Devices
Recommendation
buy
Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
GlobeNewswire • Apr 9, 2026
Read articleRedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
ACCESS Newswire • Apr 2, 2026
Read articleThree High Growth Tech Stocks in Australia
Simply Wall St. • Mar 29, 2026
Read articleNexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
GlobeNewswire • Feb 24, 2026
Read articleNexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
GlobeNewswire • Feb 23, 2026
Read articleNexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESS Newswire • Feb 13, 2026
Read article